Buprenorphine (Suboxone®)

SUBOXONE® is the first opioid medication approved under DATA 2000 for the treatment of opioid dependence in an office-based setting. SUBOXONE® also can be dispensed for take-home use, just as any other medicine for other medical conditions.The primary active ingredient in SUBOXONE® is buprenorphine.Because buprenorphine is a partial opioid agonist, its opioid effects are limited compared with those produced by full opioid agonists, such as oxycodone or heroin. SUBOXONE® also contains naloxone, an opioid antagonist.The naloxone in SUBOXONE® is there to discourage people from dissolving the tablet and injecting it. When SUBOXONE® is placed under the tongue, as directed, very little naloxone reaches the bloodstream, so what the patient feels are the effects of the buprenorphine. However, if naloxone is injected, it can cause a person dependent on a full opioid agonist to quickly go into withdrawal

SUBOXONE® at the appropriate dose may be used to:

  • Reduce illicit opioid use
  • Help patients stay in treatment  by
  • Suppressing symptoms of opioid withdrawal
  • Decreasing cravings for opioids

Stopping the use of heroin or painkillers is an important step in the treatment of opioid dependence. However, it is only the first step—the next step is not starting again.

Reducing the risk of relapse is actually something that opioid-dependent patients learn how to do. Helping patients to develop the skills to avoid the triggers and situations that might put them at risk is one of the key functions of counseling during treatment. Numerous studies have shown that long-term treatment success (ie, stopping any use of drugs of abuse) is more likely when patients regularly participate in counseling as part of their opioid dependence treatment. For further information on SUBOXONE® go to www.suboxone.com.

For  information on the treatment protocol designed for your specific medical needs,  contact RCMA at 856-227-2104

Contact Information

Blackwood Medical Center 856-227-2104—phone
141 S Black Horse Pike 856-227-2896—fax
Suite 103
Blackwood, NJ 08012  

Blackwood Medical Center

SUBOXONE® treatment can be broken down into 5 phases:

How long has SUBOXONE® been used?

Buprenorphine has been available as SUBOXONE® in the United States since 2003. In Europe, buprenorphine was introduced during the mid-90s. Today, more than 400,000 opioid-dependent patients worldwide have been treated with buprenorphine.


Site design by Atrixware